Výsledky vyhledávání - "flexible dose"

Akademický článek

Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis

Autor: April W. Armstrong, Andrew F. Alexis, Andrew Blauvelt, Jonathan I. Silverberg, Claire Feeney, Mark Levenberg, Gary Chan, Fan Zhang, Luke Fostvedt

Publikováno v: Dermatology and Therapy, Vol 14, Iss 7, Pp 1849-1861 (2024)

Abstract Introduction Early prediction of abrocitinib efficacy in atopic dermatitis (AD) could help identify candidates for an early dose increase. A predictive model determined week 12 efficacy based on week 4 responses in patients receiving abrocit

Externí odkaz: https://doaj.org/article/4fcba376017f4075bfd6d2381581d150

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain

Autor: Peral C, Sánchez-Ballester F, García-Mediero JM, Ramos J, Rejas J

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 8, Pp 541-550 (2016)

Carmen Peral,1 Francisco Sánchez-Ballester,2 José M García-Mediero,3 Jaime Ramos,1 Javier Rejas1 1Health Economics & Outcomes Research Department, Pfizer, Alcobendas (Madrid), 2Department of Urology, Hospital General Universitario de Valencia, Val

Externí odkaz: https://doaj.org/article/bef08e57591c478aa64ade4ab65baa29

Zobrazit plný text záznamu

Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder

Publikováno v: Canadian Geriatrics Journal. 25(1):72-78

BackgroundOlder patients (> 65 yr) suffering from overactive bladder (OAB) are more likely to have functional impairment and comorbidity than those without OAB. This article reviews available published studies and discusses how fesoterodine might mee

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od________83::3efa9a437f860fa17db2826f7b11abfb
https://doi.org/10.5770/cgj.25.530

Zobrazit plný text záznamu

Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder

Autor: John Heesakkers, Manon Te Dorsthorst, Adrian Wagg

Publikováno v: Canadian Geriatrics Journal, 25, 72-78
Canadian Geriatrics Journal, 25, 1, pp. 72-78

Contains fulltext : 248302.pdf (Publisher’s version ) (Open Access) BACKGROUND: Older patients (> 65 yr) suffering from overactive bladder (OAB) are more likely to have functional impairment and comorbidity than those without OAB. This article revi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdd348acc7e20f3bd7db5174520837d7
https://doi.org/10.5770/cgj.25.530

Zobrazit plný text záznamu

Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics

Autor: Guendalina Zuccari, Silvana Alfei, Danilo Marimpietri, Valentina Iurilli, Paola Barabino, Leonardo Marchitto

Publikováno v: Pharmaceuticals
Pharmaceuticals, Vol 15, Iss 108, p 108 (2022)

In the treatment of pediatric diseases, mass-produced dosage forms are often not suitable for children. Commercially available medicines are commonly manipulated and mixed with food by caregivers at home, or extemporaneous medications are routinely c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba3f48d5546817115df802c0a954601
https://hdl.handle.net/11567/1067173

Zobrazit plný text záznamu

Pharmacoeconomic analysis of flexible-dose administration regimen of Xeomine® in patients with focal dystonia

Autor: A. E. Cheberda, D. Yu. Belousov, S. K. Zyryanov

Publikováno v: Качественная клиническая практика, Vol 0, Iss 1, Pp 53-65 (2018)

Relevance. The most effective treatment for focal dystonia (blepharospasm (BsP) and cervical dystonia (CD)) is use of botulinum toxin, including onabotulinumtoxinА (BoNTA-Ona), incobotulinumtoxin А (BoNTA-Inco), abobotulinumtoxinА (BoNTA-Abo). In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::d2967bff87d244db31b1bcae0b13953d
https://www.clinvest.ru/jour/article/view/217

Zobrazit plný text záznamu

The Difference of Fasting Blood Sugar of Male Patients with Schizophrenia Treated with Flexible Dose between Aripiprazole and Risperidone in Medan, Indonesia

Autor: Nazli Mahdinasari Nasution, Vita Camellia, Elmeida Effendy, Bahagia Loebis, Trisna Marni

Publikováno v: Open Access Macedonian Journal of Medical Sciences; Vol 7 No 9 (2019): May 15 (OAMJMS); 1446-1451
Open Access Macedonian Journal of Medical Sciences, Vol 7, Iss 9 (2019)
Open Access Macedonian Journal of Medical Sciences

BACKGROUND: Life expectancy among schizophrenic patients is 20% shorter than the general population. Currently, long-term use of antipsychotic drugs can induce metabolic symptoms, including weight gain, glucose intolerance, high blood glucose. AIM: T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39a717a52c93ab1ed4c2bb14a75dc8a
http://www.id-press.eu/mjms/article/view/oamjms.2019.324

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání